Core Laboratories Stock Performance

CLB
 Stock
  

USD 13.91  1.83  11.63%   

The firm shows a Beta (market volatility) of 1.2137, which signifies a somewhat significant risk relative to the market. Let's try to break down what Core Laboratories's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Core Laboratories will likely underperform. Even though it is essential to pay attention to Core Laboratories historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Core Laboratories NV exposes twenty-one different technical indicators, which can help you to evaluate its performance. Core Laboratories has an expected return of -0.49%. Please be advised to confirm Core Laboratories value at risk, expected short fall, and the relationship between the treynor ratio and downside variance to decide if Core Laboratories performance from the past will be repeated at some point in the near future.
  
Core Laboratories Performance
0 of 100
Over the last 90 days Core Laboratories NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in October 2022. The current disturbance may also be a sign of long term up-swing for the company investors. ...more

Core Laboratories Price Channel

Quick Ratio1.33
Fifty Two Week Low13.75
Target High Price20.39
Fifty Two Week High35.83
Payout Ratio21.05%
Trailing Annual Dividend Yield0.25%
Target Low Price20.39

Core Laboratories Relative Risk vs. Return Landscape

If you would invest  2,000  in Core Laboratories NV on June 26, 2022 and sell it today you would lose (609.00)  from holding Core Laboratories NV or give up 30.45% of portfolio value over 90 days. Core Laboratories NV is generating negative expected returns assuming volatility of 3.9207% on return distribution over 90 days investment horizon. In other words, 34% of stocks are less volatile than Core Laboratories, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Daily Expected Return (%)  
       Risk (%)  
Considering the 90-day investment horizon Core Laboratories is expected to under-perform the market. In addition to that, the company is 3.55 times more volatile than its market benchmark. It trades about -0.12 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.08 per unit of volatility.

Core Laboratories Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Core Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Core Laboratories NV, and traders can use it to determine the average amount a Core Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1249

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsCLB
Estimated Market Risk
 3.92
  actual daily
 
 34 %
of total potential
 
3434
Expected Return
 -0.49
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.12
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Core Laboratories is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Core Laboratories by adding it to a well-diversified portfolio.

About Core Laboratories Performance

To evaluate Core Laboratories Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Core Laboratories generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Core Laboratories Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Core Laboratories market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Core Laboratories's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Things to note about Core Laboratories

Checking the ongoing alerts about Core Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Core Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Core Laboratories Alerts

Equity Alerts and Improvement Suggestions

Core Laboratories generated a negative expected return over the last 90 days
Core Laboratories has high historical volatility and very poor performance
On 29th of August 2022 Core Laboratories paid $ 0.01 per share dividend to its current shareholders
Continue to Trending Equities. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.